Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Atorvastatin × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Genitourinary 10 Gastrointestinal 8 Gynecologic 5 Other hematologic neoplasm 4 Lymphoid 4 CNS 4 Myeloid 2 Head & Neck 2 Plasma cell 1 Other neoplasm 1 Dermatologic 1

Conditions

Neoplasms, Plasma Cell 1

Interventions

Dexamethasone 738 Lenalidomide 392 Bortezomib 390 Cyclophosphamide 319 Melphalan 243 Calcium Dobesilate 224 daratumumab 200 pomalidomide 170 carfilzomib 152 fludarabine 117 fludarabine phosphate 108 Thalidomide 107 Filgrastim 101 Peripheral Blood Stem Cell Transplantation 100 ixazomib 82 dexamethasone acetate 75 Whole-Body Irradiation 75 Granulocyte Colony-Stimulating Factor 75 Mycophenolic Acid 70 Busulfan 70 Tacrolimus 63 dexamethasone 21-phosphate 62 auricularum 57 Prednisone 56 Cyclosporine 54 isatuximab 53 belantamab mafodotin 51 elotuzumab 48 Antilymphocyte Serum 48 Etoposide 46

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00164086 2006-10-11

Atorvastatin in Myeloma

Bayside Health

Phase 1 Unknown

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡